Clinical Trial Update: Identification of Novel Biomarkers of Cervicovaginal Mucosal Inflammation [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update from CONRAD reporting identification of novel biomarkers associated with cervicovaginal mucosal inflammation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginal Infections
• Vaginal Inflammation

Snippet

Sponsor: CONRAD | Conditions: Vaginal Inflammation, Vaginal Infections | Phase 2 | Status: COMPLETED